Lemaitre Vascular (LMAT) Accumulated Expenses (2016 - 2025)
Lemaitre Vascular (LMAT) has disclosed Accumulated Expenses for 16 consecutive years, with $2.8 million as the latest value for Q4 2025.
- Quarterly Accumulated Expenses fell 81.8% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, down 81.8% year-over-year, with the annual reading at $2.8 million for FY2025, 81.8% down from the prior year.
- Accumulated Expenses for Q4 2025 was $2.8 million at Lemaitre Vascular, down from $16.2 million in the prior quarter.
- The five-year high for Accumulated Expenses was $23.6 million in Q4 2023, with the low at $2.4 million in Q2 2025.
- Average Accumulated Expenses over 5 years is $11.8 million, with a median of $11.0 million recorded in 2022.
- The sharpest move saw Accumulated Expenses skyrocketed 563.63% in 2024, then crashed 88.31% in 2025.
- Over 5 years, Accumulated Expenses stood at $10.2 million in 2021, then rose by 5.22% to $10.8 million in 2022, then surged by 119.59% to $23.6 million in 2023, then tumbled by 36.08% to $15.1 million in 2024, then tumbled by 81.8% to $2.8 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods came in at $2.8 million, $16.2 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.